Search research articles
Contact Us
Filters
Showing results (81-90 of 164) with videos related to
Page
of 17
Sort By:
International Journal of Laboratory Hematology
|
July 10, 2007
Guidelines on the insertion and management of central venous access devices in adults
L Bishop, L Dougherty, A Bodenham, et al.
British Journal of Cancer
|
August 1, 1987
Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement
M Brada, S Mizutani, H Molgaard, et al.
Lancet (London, England)
|
December 13, 1986
Paraplegia after intrathecal mitozantrone
A K Lakhani, A G Zuiable, C M Pollard, et al.
Journal of Clinical Apheresis
|
January 1, 1997
Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignancies
J Mehta, R Powles, J Treleaven, et al.
Leukemia & Lymphoma
|
July 1, 1992
Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation
C Tiley, R Powles, J Catalano, et al.
Bone Marrow Transplantation
|
June 12, 2002
Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?
J Mehta, R Powles, B Sirohi, et al.
Leukemia & Lymphoma
|
March 1, 1994
Cimetidine-induced myelosuppression after bone marrow transplantation
J Mehta, R L Powles, J Treleaven, et al.
Leukemia & Lymphoma
|
September 24, 1999
The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy
J Mehta, R Powles, J Treleaven, et al.
Bone Marrow Transplantation
|
July 3, 2003
Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes?
J Mehta, R Powles, B Sirohi, et al.
Bone Marrow Transplantation
|
April 1, 1996
Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission
S Singhal, R Powles, J Treleaven, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 164) with videos related to
Sort By:
Page
of 17
International Journal of Laboratory Hematology
|
July 10, 2007
Guidelines on the insertion and management of central venous access devices in adults
L Bishop, L Dougherty, A Bodenham, et al.
British Journal of Cancer
|
August 1, 1987
Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement
M Brada, S Mizutani, H Molgaard, et al.
Lancet (London, England)
|
December 13, 1986
Paraplegia after intrathecal mitozantrone
A K Lakhani, A G Zuiable, C M Pollard, et al.
Journal of Clinical Apheresis
|
January 1, 1997
Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignancies
J Mehta, R Powles, J Treleaven, et al.
Leukemia & Lymphoma
|
July 1, 1992
Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation
C Tiley, R Powles, J Catalano, et al.
Bone Marrow Transplantation
|
June 12, 2002
Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?
J Mehta, R Powles, B Sirohi, et al.
Leukemia & Lymphoma
|
March 1, 1994
Cimetidine-induced myelosuppression after bone marrow transplantation
J Mehta, R L Powles, J Treleaven, et al.
Leukemia & Lymphoma
|
September 24, 1999
The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy
J Mehta, R Powles, J Treleaven, et al.
Bone Marrow Transplantation
|
July 3, 2003
Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes?
J Mehta, R Powles, B Sirohi, et al.
Bone Marrow Transplantation
|
April 1, 1996
Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission
S Singhal, R Powles, J Treleaven, et al.
Page
of 17